Contributed by Akshi Seem, Associate Partner Read More: #PatentLaw #DelhiHighCourt #AccessToMedicine #Pharma #IntellectualProperty #MaheshwariAndCo To view or add a comment, sign in CANADA APPROVES NEW PATENT The Canadian Intellectual Property Office / Office de la proprit intellectuelle du Canada (CIPO) has granted Palisade Bio a patent for its PALI-2108 therapy, a gut-targeted PDE4 B/D inhibitor being developed for ulcerative colitis (UC) and fibrostenotic Crohns disease (FSCD)
Supplementation with 4,000 IU/day of vitamin D for 2 months significantly increased serum 25-(OH) D3 levels and markedly decreased the LH/FSH ratio, LH, and T concentrations, and improved pregnancy rates following ovulation induction (41)
As of April 2026, tirzepatide remains on the shortage list, allowing compounding
Therefore, understanding and addressing the inflammatory component of diabetes is crucial for the development of effective therapeutic strategies aimed at preventing or mitigating complications associated with this disease
Kawamoto, Y., Wu, Y., Takahashi, Y